Home › Employers › Quality Pharmacy Corp
Quality Pharmacy Corp: H-1B salaries and sponsorship
Quality Pharmacy Corp filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $60,754.
Does Quality Pharmacy Corp sponsor H-1B visas?
Quality Pharmacy Corp filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 6, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Regulatory and Compliance Analyst | 2 | $59,434 |
| Pharmacist | 1 | $121,014 |
| Pharmacy Manager Services | 1 | $59,509 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2025 | 4 | $60,754 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Pharmacy Manager Services | $59,509 Level I | Worcester, MA | Jun 6, 2025 | Oct 1, 2025 | Certified |
| Regulatory and Compliance Analyst | $56,867 Level I | Worcester, MA | Jun 5, 2025 | Oct 1, 2025 | Certified |
| Pharmacist | $121,014–$125,000 Level II | Selden, NY | Oct 23, 2024 | Dec 2, 2024 | Certified |
| Regulatory and Compliance Analyst | $62,000 Level I | Worcester, MA | Oct 2, 2024 | Oct 2, 2024 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).